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Acute effect of a supplemented milk drink
on bone metabolism in healthy postmenopausal
women is influenced by the metabolic syndrome
Sunethra D. C. Thomas1,2*, Howard A. Morris3,4 and B. E. C. Nordin2ˆ
Abstract
Background: Dietary factors acutely influence the rate of bone resorption, as demonstrated by changes in serum
bone resorption markers. Dietary calcium exerts its effect by reducing parathyroid hormone levels while other
components induce gut incretin hormones both of which reduce bone resorption markers. The impact of dietary
calcium on bone turnover when energy metabolism is modulated such as in metabolic syndrome has not been
explored. This study was designed investigate whether metabolic syndrome or a greater amount of visceral fat
influences the impact of dietary calcium on bone turnover.
Methods: The influence of the metabolic syndrome on effects of dietary calcium on bone turnover in community
dwelling postmenopausal women was studied. Twenty five volunteers consumed 200 mL of low fat milk with
additional 560 mg calcium (one serve of Milo®) in the evening on one occasion. Fasting morning serum biochemistry
before and after the milk drink with lumber spine bone density, bone mineral content, fat and lean mass
using dual energy X-ray absorptiometry (DXA) and waist circumference were measured. The women were
divided into 2 groups using the waist measurement of 88 cm, as a criterion of metabolic syndrome. Student’s
t tests were used to determine significant differences between the 2 groups.
Results: The lumbar spine mineral content was higher in women with metabolic syndrome. After consuming
the milk drink, serum bone resorption marker C terminal telopeptide (CTX) was suppressed to a significant
extent in women with metabolic syndrome compared to those without.
Conclusions: The results suggests that dietary calcium may exert a greater suppression of bone resorption in
post-menopausal women with metabolic syndrome than healthy women. Despite substantial evidence for close links
between energy metabolism and bone metabolism this is the first report suggesting visceral fat or metabolic
syndrome may influence the effects of dietary calcium on bone metabolism.
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Introduction
Osteoporosis is common in postmenopausal women, in
which estrogen deficiency plays an important role. Low
dietary calcium intake and vitamin D deficiency also con-
tribute to the high prevalence of osteoporosis amongst
these women. Post-menopausal bone loss is driven by
increased rate of bone resorption relative to bone forma-
tion which is demonstrated biochemically by an increase
in serum levels of metabolites of type I collagen.
Dietary calcium and vitamin D are essential for skel-
etal health throughout life and are recognised as bone
sparing nutrients [1, 2]. The calcium requirement rises
after the menopause due to increased losses and reduced
intestinal absorption [3, 4].
The main dietary source of calcium is dairy food with
high calcium bioavailability and optimal ratio of calcium
to phosphate optimal for intestinal absorption [5].
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Regular intake of vitamin D-fortified, calcium rich food,
such as dairy inhibits markers of bone resorption in post-
menopausal women -within 4 to 8 weeks [6–8]. An inad-
equate dietary calcium intake in post-menopausal women
leads to increased risk of osteoporosis and fragility frac-
tures [9]. However a longitudinal prospective cohort study
did not show a reduction in fracture risk or osteoporosis
rates with an increased dietary calcium intake [10].
The variable results in terms of bone mineral density
and fracture reduction may arise from factors other than
dietary calcium and vitamin D influencing bone metab-
olism. Among these factors, energy nutrients as well as
dysregulation of metabolic pathways as occurs in meta-
bolic syndrome may be important factors.
To our knowledge, the acute effects of dietary calcium
on bone metabolism in the context of metabolic syndrome
in postmenopausal women have not been evaluated. The
present study determined the interaction between a single
evening supplemented milk drink and anthropormetric
and biochemical measures of metabolic syndrome on
bone resorption in post-menopausal women. The aim is
to investigate if metabolic syndrome or a greater amount
of visceral fat influences the impact of dietary calcium on
bone resorption in post-menopausal women.
Method
Participant recruitment
Ethics approval as granted by the Royal Adelaide Human
Research Ethics Committee (Protocol number 09071; 29th
July 2009). Community dwelling postmenopausal women
who participated in a non interventional observational
study were invited to participate in the current study.
They completed a general health, a dietary calcium intake
questionnaire and a consent form. Subjects who were tak-
ing calcium supplements were instructed to cease the sup-
plements for 7 days prior to participation.
Intervention
On the day of the study each subject had morning fasting
blood samples collected for routine electrolytes, liver func-
tion, creatinine, urea, total cholesterol, glucose, calcium,
phosphate (analysed by Olympus AU 5700, Olympus
Japan), parathyroid hormone (PTH,—Immulite 2000, Sie-
mens Healthcare Australia), 25OH vitamin D (25OHD)
(IDS-iSYS, Immunodiagnostic Systems, −UK) and C-
terminal telopeptide of type I collagen (CTX,—Roche E170,
Roche Diagnostics, Australia). Subjects were provided with
Pura Tone milk (Pura, Victoria, Australia) (1 L) and a sa-
chet of Milo (Nestle, Australia) (20 g) with a 200 mL plastic
measuring cup. They were instructed to measure out
200 mL milk (containing 400 mg Ca, 10 g protein, 13.5 g
carbohydrate) and add the sachet of Milo (containing
160 mg Ca, 2.6 g protein, 13.3 g carbohydrate). The drink
(containing a total of 560 mg Ca) either warm or cold, was
taken at 9 pm the same night as the blood test. The
next morning another set of fasting blood samples
were collected from each subject to repeat the assays
of the biochemical variables, except for 25OHD. All
subjects had a radiocalcium absorption study per-
formed using 45Ca [11]) within 12 months of the study
and a DXA bone mineral density measurement (Norland
XR 36, Swissray International Switzerland) within 6 months
of the study. An abdominal fat and lean mass obtained
from the lumbar spine DXA, height, weight and waist cir-
cumference (WC) were recorded. Subjects—completed a
validated food frequency questionnaire to ascertain their
habitual dietary calcium intake.
Subjects were divided into 2 groups according to their
WC using 88 cm as a cut off with WC > 88 cm indicat-
ing metabolic syndrome (ATP III criteria) [12]. WC was
chosen to categorise subjects into metabolic syndrome
because it compares closely with the BMI and visceral
fat. Waist circumference is also the theme of a public
education campaign conducted by the Heart Foundation
of Australia [13]. The Heart Foundation recommends
measuring the waist circumference as an inexpensive
and non-invasive method to indicate visceral fat and a
predictor of risk for chronic disease such as diabetes and
heart disease.
Statistical analysis
A Student’s t test was performed to determine significant
difference between measured variables before and after
the supplemented milk drink, and also differences be-
tween the metabolic syndrome women and lean women.
Linear regression analysis and a correlation matrix were
used to determine correlations between variables.
Results
Twenty five postmenopausal women volunteered to par-
ticipate in the study. Demographic data and anthropo-
metric measurements are given in Table 1.
Their mean fractional calcium absorption was 0.67
(range 0.33 to 1.24; normal >0.5) and mean urine calcium/
creatinine ratio was 0.28 (range 0.03 to 0.73; reference
interval 0.03–0.4). There was no significant difference in
Table 1 Demographic and anthropometric data for all subjects
Variable Mean SD Range
Age (years) 63 5 51–71
Years since menopause 12 7 1–28
Height (m) 1.62 0.05 1.55–1.71
Weight (kg) 66 9 50–81
Waist circumference (cm) 84 9 67–99
BMI (kg/m2) 24.9 3 20–31
Habitual daily Ca intake (dietary; mg) 1012 260 642–1605
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the fractional calcium absorption, urinary calcium excre-
tion or habitual daily calcium intake between the women
with and without metabolic syndrome, as defined by a
WC> 88 cm.
Serum CTX levels, a marker of bone resorption, was
negatively related to abdominal fat mass (Fig. 1) and
serum 25OHD was negatively related to WC (P < 0.01)
amongst all the subjects at baseline. Biochemical vari-
ables before and after the supplemented milk drink for
all women are presented in Table 2. Only ionised cal-
cium changed significantly after the supplemented milk.
WC, fasting blood glucose and lipid profiles were avail-
able as determinants of metabolic syndrome in these
women. Fasting blood glucose of >5.6 mmol/L, triglycer-
ide >1.7 mmol/L and HDL < 1.29 mmol/L (as suggested
by the American Heart Foundation) [14] were not used
because these biochemical criteria did not distinguish be-
tween the 2 groups. In support of the use of WC as a
marker of metabolic syndrome the change in blood glu-
cose after the supplemented milk drink correlated with
WC, abdominal fat mass and body weight (P < 0.01).
Table 3 represents the anthropomorphic measures on
the two groups based on WC (<88 cm compared with >
88 cm). There was no significant difference in the frac-
tional calcium absorption, urinary calcium excretion or
habitual daily calcium intake between them. Lumbar
spine bone mineral content was increased and bone
mineral density tended to be higher in those with a
greater WC (≥88 cm). These women also had a signifi-
cantly greater abdominal fat mass, body weight and BMI
than those with WC < 88 cm. There was no significant
difference in height or lean mass between the groups.
Table 3 also presents the measured biochemical variables
in women with WC <88 cm and with WC ≥88 cm.
The changes in measured biochemical variables after
the supplemented milk drink in women with and with-
out metabolic syndrome are presented in Table 4. The
changes in bone turnover markers ALP and CTX and
the calciotropic hormone PTH in each group after the
milk drink are depicted in Fig. 2. Women with a larger
WC responded to the supplemented milk drink with a
significant fall in CTX levels with the fall in ALP tending
to significance. There is no evidence that these changes
in bone turnover in women with metabolic syndrome
are mediated by changes in PTH.
Discussion
Weight, abdominal fat mass, BMI and lumbar spine bone
mineral content were significantly greater in women
whose WC greater than or equal to 88 cm. The lumbar
bone density was also higher in these women, but the
difference did not achieve statistical significance. There
were no significant differences in the biochemical vari-
ables or daily dietary calcium intake between the 2
groups of women. Serum 25OHD level was negatively
correlated with WC implying that overweight or obese
states or metabolic syndrome may be associated with
lower vitamin D status.
Following the supplemented milk drink, only ionized
Ca changed significantly from baseline. After this drink,
the fall in CTX was only significant in women with a
WC ≥88 cm and not in those with a WC <88 cm.
Dietary calcium when ingested with a meal including a
dairy drink, is influenced by other co-ingested nutrients
likely to influence bioavailability and metabolism of cal-
cium. The effect of carbohydrate on bone metabolism is
marked and acts through the increase in plasma levels of
incretin hormones, particularly glucagon-like peptide 2
(GLP-2) [15]. Osteocalcin, a protein produced by the
bone forming osteoblasts is considered to provide a link
between energy metabolism and bone [16]. The absence
of osteocalcin reduces beta cell proliferation and leads to
glucose intolerance and insulin resistance. Osteocalcin is
thought to sensitize adipocytes to insulin via adiponectin,
Fig. 1 Visceral fat mass is significantly inversely related to baseline fasting CTX in all subjects (R2 = 0.18; P = 0.04)
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thereby improving glucose tolerance. These findings sug-
gest that bone turnover is intimately associated with carbo-
hydrate metabolism and insulin sensitivity or resistance.
In addition protein plays a major role in calcium
homeostasis, presumably via IGF-1 [17]. Indeed, medium
term studies on dietary calcium intakes show a rise in
IGF-1 due to protein in cheese with a concurrent fall in
bone turnover markers. Very low protein diets result in
hypocalciuria, low fractional calcium absorption and sec-
ondary hyperparathyroidism while a high protein diet en-
hances fractional calcium absorption and consequent
urinary calcium excretion [18].
Nutrient intake and caloric intake, among other fac-
tors, plays a major role in the development of metabolic
syndrome. Metabolic syndrome, due to derangement in
various metabolic processes such as insulin resistance,
may influence the handling of ingested nutrients.
Obesity may protect mammals from osteoporosis, and
bone metabolism may indeed be linked to energy metab-
olism. This link may be the hormones exerting their ef-
fects on both bone and energy metabolism under the
influence of the hypothalamus [19]. This concept of a
gut-brain-bone axis has led to investigations on the ef-
fects of nutrients on enteroendocrine cells, and the ef-
fect of their secretions (incretins or gut derived
hormones) on bone and other tissue. The proposed link
between incretins and bone is an evolving concept in
nutrient-dependent regulation of bone turnover. The
postprandial fall in bone resorption markers and the rise
in bone formation markers (albeit to a lesser extent) has
been attributed to the effects of incretins GLP-1 mainly,
with GLP-2 playing a minor role [20, 21].
The adipocyte derived hormone, leptin is a major
regulator of osteoblast function, and inhibit bone
Table 2 Biochemical variables before and after the supplemented milk drink
Variable Before drink [mean (SD)] After drink [mean (SD)] Level of significance
Glucose mmol/L 4.9 (1) 4.8 (1) 0.4
Total cholesterol mmol/L 5.6 (1) 5.6 (1) 0.4
Total Ca mmol/L 2.37 (0.08) 2.4 (0.09) 0.12
Ionised Ca mmol/L 1.21 (0.04) 1.23 (0.04) 0.05*
Phosphate mmol/L 1.18 (0.13) 1.22 (0.13) 0.15
ALP IU/L 75 (19) 71 (20) 0.24
CTX ng/L 432 (132) 416 (143) 0.3
PTH pmol/L 4.3 (1.1) 4 (1) 0.13
25 OHD nmol/L 88 (26) NA NA
*P = 0.05
Table 3 Anthropometric and biochemical measuresfor the 2 groups of subjects
Anthropometric measurement Subjects with waist circumference <88 cm;
mean (SD) N = 16
Subjects with waist circumference ≥88 cm;
mean (SD) N = 8
P
Lumbar spine BMD g/cm2 1.039 (0.212) 1.167 (0.115) 0.06
Lumbar spine BMC g 45.35 (9.95) 55.46 (8.75) 0.011*
Lean mass g 1567 (190) 1540 (253) 0.38
Fat mass g 655 (222) 1071 (132) 0.000**
Height m 1.63 (0.05) 1.63 (0.04) 0.47
Weight kg 62.5 (8.9) 73 (5.6) 0.003*
Waist circumference cm 79 (7) 94 (3) 0.000**
BMI kg/m2 23.57 (2.52) 27.59 (2.38) 0.000**
Fasting glucose mmol/L 4.65 0.49) 5.34 (1.8) 0.08
Total cholesterol mmol/L 5.48 (0.8) 5.98 (0.8) 0.13
Triglycerides mmol/L 0.99 (0.37) 1.24 (0.43) 0.11
HDL mmol/L 1.74 (0.37) 1.6 (0.14) 0.21
LDL mmol/L 3.23 (0.69) 3.6 (1.23) 0.11
*P </=0.01
**P <0.001
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formation in vivo [22, 23]. Leptin deficient or leptin re-
ceptor deficient mice display an osteopetrotic skeletal
phenotype at an early age with high trabecular bone vol-
ume [24], however there was a demonstrable decline in
the rate of bone formation (BFR) and resorption (BRR).
Interestingly, peripheral administration of leptin cor-
rected BFR and BRR demonstrating that leptin was dir-
ectly involved in regulating bone turnover. In contrast,
in humans, low circulating leptin was associated with
low bone density [25].
As in any other endocrine pathway, it can be postu-
lated that adipocytes and leptin production in turn,
may be under a feedback regulatory control of bone
metabolism. Osteocalcin, an osteoblast specific pro-
tein, seems a suitable candidate. Indeed, glucose in-
tolerance and greater amounts of visceral fat were
noted in Osteocalcin knockout mice (Osteocalcin−/−)
[16]. Furthermore, deletion of other genes in osteo-
blasts in mice led to pancreatic β cell proliferation, a
rise in insulin secretion and sensitivity that protected
against obesity and diabetes, demonstrating at least
the capacity of osteoblasts to contribute to energy
metabolism. It follows then that deranged energy me-
tabolism, as in the metabolic syndrome with glucose
intolerance and greater visceral fat, may influence
bone metabolism. We hypothesis that responses of
bone metabolism to dietary calcium may differ be-
tween women with and without metabolic syndrome.
Conclusions
Given that there were no differences in calcium absorp-
tion or the rate of urinary calcium excretion between the
2 groups of women, the findings reported here suggest
that metabolic syndrome may have influenced the fall of
CTX in response to dietary Ca. There was a trend for
baseline CTX to be lower in women with higher visceral
fat. These findings are consistent with previous proposed
theories of obesity protecting against osteoporosis pre-
sumably via leptin and hypothalamic feedback, closely
associated with energy metabolism [19]. Our data also
imply that bone turnover in overweight women or
women with metabolic syndrome was more sensitive to
dietary calcium intake.
Table 4 Changes in biochemical variables after the supplemented milk drink in the 2 groups of subjects
Variable Change after the supplemented milk drink in women
with WC < 88 cm; mean (SD)
Change after the supplemented milk drink in women
with WC =/> 88 cm; mean (SD)
P
Glucose mmol/L −0.11 (0.5) −0.1 (0.36) 0.08
Total cholesterol mmol/L −0.05 (0.33) 0.09 (0.19) 0.1
PO4 mmol/L 0.03 (0.12) 0.06 (0.04) 0.24
Total Ca mmol/L 0.03 (0.07) 0.02 (0.04) 0.35
Ionised Ca mmol/L 0.02 (0.04) 0.02 (0.03) 0.35
ALP IU/L −0.9 (5.7) −10.6 (24.3) 0.07
CTX ng/L −0.33 (37.46) −53 (45.2) 0.003*
PTH pmol/L −0.4 (0.65) −0.57 (0.66) 0.27
*P <0.005
Fig. 2 Change in ALP, CTX and PTH (in units as indicated) after the supplemented milk drink in subjects with WC <88 cm and ≥88 cm. The fall in
serum CTX was statistically significant (P = 0.003)
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